Christopher Gomez

Christopher A. Gomez has experience in a wide range of legal matters, from representing plaintiffs and defendants, practicing in state and federal courts, and litigating matters from personal injury to mass torts to whistleblower litigation. And he has had success every step of the way. In his most recent courtroom victory, in October 2019, Gomez was co-counsel with Tom Kline in a case that produced an $8 billion jury verdict against Johnson & Johnson and subsidiary Janssen Pharmaceuticals, the maker of the anti-psychotic drug Risperdal, which has been linked to the abnormal growth of female breast tissue in boys, known as gynecomastia. The verdict, for punitive damages, was handed down in Philadelphia Common Pleas Court and is believed to be the largest in Pennsylvania history and among the largest ever in the nation.

Gomez also has been co-counsel in several other trials against Janssen over its failure to warn about the risks of Risperdal, with one case resulting a $2.5 million verdict for a young autistic man afflicted with the ailment. In another case, Gomez, a partner at Kline & Specter, teamed with attorneys from Cleveland and Pensacola in winning a $20 million Philadelphia jury verdict against J&J for injuries suffered by a New Jersey woman implanted with a vaginal mesh device. The award, $2.5 million in compensatory and $17.5 million in punitive damages, followed a three-week trial in which Gomez cross-examined a key liability and causation expert. Prior to joining Kline & Specter, Gomez worked at Sheller, PC, which pioneered Risperdal cases against Janssen, a Johnson & Johnson subsidiary.

He was Sheller's leader of case management, electronic discovery and litigation strategy. He also conducted pre-trial discovery and depositions. An experienced trial lawyer, Gomez has represented clients in cases involving defective medical devices and general product liability claims, representing both individual clients and working on class action litigation. He has represented both plaintiffs and defendants including corporations, giving him broad perspective on litigation involving medical malpractice and other personal injury cases as well as mass torts.

His work has earned him recognition by the independent review group Pennsylvania Super Lawyers for 14 straight years (2013-2026). Gomez also has been named to Best Lawyers in America. Before working at the Sheller firm, Gomez worked at The Miller Firm on mass tort pharmaceutical litigation, handling discovery and settlement negotiations involving a litany of other problematic drugs, among them Vioxx, Bextra, Zyprexa, Avandia and the diet drug Fen-Phen. He managed a client base of more than 5,000 at the firm, which has offices in Pennsylvania and Virginia.

Gomez is licensed to practice in both states. Gomez earned his bachelor's degree at North Carolina State University and his law degree at Widener University School of Law, where he graduated in the top third of his class and was a member of the student government and the Moot Court Honor Society. He is a member of the Pennsylvania and Virginia bar associations.